Therapy Optimisation for the Treatment of Hairy Cell Leukemia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Hairy Cell Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Community based hemato-oncology medical office, Ansbach, Germany

    Contact: Study coordinator (Sebastian Müller, PhD)
    Contact: Principal Investigator (Sebastian Müller, PhD)
  • Community based hemato-oncology medical office, Aschaffenburg, Germany

    Contact: Study coordinator (Manfred Welslau, PhD)
    Contact: Principal Investigator (Manfred Welslau, PhD)
  • Rhön-Saale-Klinik gGmbH, Bad Neustadt an der Saale, Germany

    Contact: Study coordinator (Klaus Wutke, PhD)
    Contact: Principal Investigator (Klaus Wutke, PhD)
  • Community based hemato-oncology medical office, Berlin, Germany

    Contact: Study coordinator (Herbert Lebahn, PhD)
    Contact: Principal Investigator (Herbert Lebahn, PhD)
  • Charité - Universitätsmedizin Berlin, Berlin, Germany

    Contact: Study coordinator (Eckhard Thiel, Prof PhD)
    Contact: Principal Investigator (Eckhard Thiel, Prof PhD)
  • Community based hemato-oncology medical office, Bremen, Germany

    Contact: Study coordinator (Karl Wietholt, PhD)
    Contact: Principal Investigator (Karl Wietholt, PhD)
  • Community based hemato-oncology medical office, Celle, Germany

    Contact: Study coordinator (Felix Marquard, PhD)
    Contact: Principal Investigator (Felix Marquard, PhD)
  • Community based hemato-oncology medical office, Cottbus, Germany

    Contact: Study coordinator (Ulrich von Grünhagen, PhD)
    Contact: Principal Investigator (Ulrich von Grünhagen, PhD)
  • Community based hemato-oncology medical office, Darmstadt, Germany

    Contact: Study coordinator (Georgi Kojouharoff, PhD)
    Contact: Principal Investigator (Georgi Kojouharoff, PhD)
  • Community based hemato-oncology medical office, Dresden, Germany

    Contact: Study coordinator (Steffen Dörfel, PhD)
    Contact: Principal Investigator (Steffen Dörfel, PhD)
  • Community based hemato-oncology medical office, Duisburg, Germany

    Contact: Study coordinator (Johannes Selbach, PhD)
    Contact: Principal Investigator (Johannes Selbach, PhD)
  • Klinik Duisburg-West, Duisburg, Germany

    Contact: Study coordinator (Rüdiger Lang, PhD)
    Contact: Principal Investigator (Rüdiger Lang, PhD)
  • Universitätsklinik Düsseldorf, Düsseldorf, Germany

    Contact: Study coordinator (Guido Kobbe, PhD)
    Contact: Principal Investigator (Guido Kobbe, PhD)
  • Community based hemato-oncology medical office, Ehingen, Germany

    Contact: Study coordinator (Martin Simon, PhD)
    Contact: Principal Investigator (Martin Simon, PhD)
  • Community based hemato-oncology medical office, Erlangen, Germany

    Contact: Study coordinator (Michael J Eckart, PhD)
    Contact: Principal Investigator (Michael J Eckart, PhD)
  • Community based hemato-oncology medical office, Frankfurt, Germany

    Contact: Study coordinator (Wolfgang U Knauf, Prof PhD)
    Contact: Principal Investigator (Wolfgang U Knauf, Prof PhD)
  • Krankenhaus Nordwest, Frankfurt, Germany

    Contact: Study coordinator (Eckhart Weidmann, Prof PhD)
    Contact: Principal Investigator (Eckhart Weidmann, Prof PhD)
  • Community based hemato-oncology medical office, Freiburg im Breisgau, Germany

    Contact: Study coordinator (Matthias Zaiss, PhD)
    Contact: Principal Investigator (Matthias Zaiss, PhD)
  • Community based hemato-oncology medical office, Friedrichshafen, Germany

    Contact: Study coordinator (Helmut Oettle, PhD)
    Contact: Principal Investigator (Helmut Oettle, PhD)
  • Community based hemato-oncology medical office, Fürth, Germany

    Contact: Study coordinator (Harald Wagner, PhD)
    Contact: Principal Investigator (Harald Wagner, PhD)
  • Community based hemato-oncology medical office, Germering, Germany

    Contact: Study coordinator (Johann Mittermüller, PhD)
    Contact: Principal Investigator (Johann Mittermüller, PhD)
  • Community based hemato-oncology medical office, Giessen, Germany

    Contact: Study coordinator (Georg Ch Schließer, PhD)
    Contact: Principal Investigator (Georg Ch Schließer, PhD)
  • University Clinic | Medicinal Clinic IV, Giessen, Germany

    Contact: Study coordinator (Mathias J Rummel, Prof. Dr.) · mathias.rummel@innere.med.uni-giessen.de · +4964198542
    Contact: Study coordinator (Juergen Barth) · juergen.barth@innere.med.uni-giessen.de · +4964198542
    Contact: Principal Investigator (Mathias J Rummel, Prof. Dr.)
  • St.-Marien-Hospital, Hagen, Germany

    Contact: Study coordinator (H W Lindemann, PhD)
    Contact: Principal Investigator (H W Lindemann, PhD)
  • Community based hemato-oncology medical office, Halle, Germany

    Contact: Study coordinator (Robert Rohrberg, PhD)
    Contact: Principal Investigator (Robert Rohrberg, PhD)
  • Evangelisches Krankenhaus, Hamm, Germany

    Contact: Study coordinator (Jörg Schubert, Prof PhD)
    Contact: Principal Investigator (Jörg Schubert, Prof PhD)
  • Community based hemato-oncology medical office, Hanau, Germany

    Contact: Study coordinator (Gerd Lautenschläger, PhD)
    Contact: Principal Investigator (Gerd Lautenschläger, PhD)
  • Community based hemato-oncology medical office, Heidelberg, Germany

    Contact: Study coordinator (Stefan Fuxius, PhD)
    Contact: Principal Investigator (Stefan Fuxius, Phd)
  • Community based hemato-oncology medical office, Herne, Germany

    Contact: Study coordinator (Lars Hahn, PhD)
    Contact: Principal Investigator (Lars Hahn, PhD)
  • Marienkrankenhaus, Herne, Germany

    Contact: Study coordinator (Dirk Strumberg, Prof PhD)
    Contact: Principal Investigator (Dirk Strumberg, Prof PhD)
  • Community based hemato-oncology medical office, Homberg (Ohm), Germany

    Contact: Study coordinator (Wolfgang Weber, PhD)
    Contact: Principal Investigator (Wolfgang Weber, PhD)
  • Community based hemato-oncology medical office, Kaiserslautern, Germany

    Contact: Study coordinator (Manfred Reeb, PhD)
    Contact: Principal Investigator (Manfred Reeb, PhD)
  • Städtisches Klinikum, Karlsruhe, Germany

    Contact: Study coordinator (Martin Bentz, Prof. PhD)
    Contact: Principal Investigator (Martin Bentz, Prof. PhD)
  • Community based hemato-oncology medical office, Kassel, Germany

    Contact: Study coordinator (Ulrike Söling, PhD)
    Contact: Principal Investigator (Ulrike Söling, PhD)
  • Klinikum Kempten-Oberallgäu, Kempten, Germany

    Contact: Study coordinator (Otto Prümmer, PhD)
    Contact: Principal Investigator (Otto Prümmer, PhD)
  • Community based hemato-oncology medical office, Koblenz, Germany

    Contact: Study coordinator (Rudolf Weide, Prof PhD)
    Contact: Principal Investigator (Rudolf Weide, Prof PhD)
  • Community based hemato-oncology medical office, Krefeld, Germany

    Contact: Study coordinator (Michael Neise, PhD)
    Contact: Principal Investigator (Michael Neise, PhD)
  • Community based hemato-oncology medical office, Kronach, Germany

    Contact: Study coordinator (Martina Stauch, PhD)
    Contact: Principal Investigator (Stauch Martina, PhD)
  • Community based hemato-oncology medical office, Landau, Germany

    Contact: Study coordinator (Eva Huntenburg, PhD)
    Contact: Principal Investigator (Eva Huntenburg, PhD)
  • Community based hemato-oncology medical office, Landshut, Germany

    Contact: Study coordinator (Ursula Vehling-Kaiser, PhD)
    Contact: Principal Investigator (Ursula Vehling-Kaiser, PhD)
  • Community based hemato-oncology medical office, Landshut, Germany

    Contact: Study coordinator (Barbara Kempf, PhD)
    Contact: Principal Investigator (Barbara Kempf, PhD)
  • Klinikum Leverkusen GmbH, Leverkusen, Germany

    Contact: Study coordinator (Norbert Niederle, Prof PhD)
    Contact: Principal Investigator (Norbert Niederle, Prof PhD)
  • St. Marienkrankenhaus, Ludwigshafen, Germany

    Contact: Study coordinator (H Weiss, Prof PhD)
    Contact: Principal Investigator (H Weiss, Prof PhD)
  • Community based hemato-oncology medical office, Lüdenscheid, Germany

    Contact: Study coordinator (Dietrich Kämpfe, PhD)
    Contact: Principal Investigator (Dietrich Kämpfe, PhD)
  • Universitätsklinik Mainz, Mainz, Germany

    Contact: Study coordinator (Georg Heß, PhD)
    Contact: Principal Investigator (Georg Heß, PhD)
  • Community based hemato-oncology medical office, Marburg, Germany

    Contact: Study coordinator (Christina Balser, PhD)
    Contact: Principal Investigator (Christina Balser, PhD)
  • Community based hemato-oncology medical office, Mönchengladbach, Germany

    Contact: Study coordinator (Ulrich Grabenhorst, PhD)
    Contact: Principal Investigator (Ulrich Grabenhorst, PhD)
  • Community based hemato-oncology medical office, München, Germany

    Contact: Study coordinator (Peter Bojko, PhD)
    Contact: Principal Investigator (Peter Bojko, PhD)
  • University Clinic Großhadern, München, Germany

    Contact: Study coordinator (Martin Dreyling, Prof PhD)
    Contact: Principal Investigator (Martin Dreyling, Prof PhD)
  • Community based hemato-oncology medical office, Neumarkt, Germany

    Contact: Study coordinator (Ekkehart Ladda, PhD)
    Contact: Principal Investigator (Ekkehart Ladda, PhD)
  • Community based hemato-oncology medical office, Nuremberg, Germany

    Contact: Study coordinator (Michael Schauer, PhD)
    Contact: Principal Investigator (Michael Schauer, PhD)
  • Community based hemato-oncology medical office, Nuremberg, Germany

    Contact: Study coordinator (Joachim Zimber, PhD)
    Contact: Principal Investigator (Joachim Zimber, PhD)
  • St. Clemens Hospital, Oberhausen, Germany

    Contact: Study coordinator (Jutta Schneider, PhD)
    Contact: Principal Investigator (Jutta Schneider, PhD)
  • St. Martinus-Hospital, Olpe, Germany

    Contact: Study coordinator (Clemens Müller-Naendrup, PhD)
    Contact: Principal Investigator (Clemens Müller-Naendrup, PhD)
  • Community based hemato-oncology medical office, Osnabrück, Germany

    Contact: Study coordinator (Gertrud Lenzen, PhD)
    Contact: Principal Investigator (Gertrud Lenzen, PhD)
  • St. Josefs-Krankenhaus, Potsdam, Germany

    Contact: Study coordinator (Michael Göner, PhD)
    Contact: Principal Investigator (Michael Göner, PhD)
  • Community based hemato-oncology medical office, Rehling, Germany

    Contact: Study coordinator (Stephan Hochdörfer, PhD)
    Contact: Principal Investigator (Stephan Hochdörfer, PhD)
  • Community based hemato-oncology medical office, Rüsselsheim am Main, Germany

    Contact: Study coordinator (Michael Baldus, Phd)
    Contact: Principal Investigator (Michael Baldus, Phd)
  • Caritas Klinik St. Theresia, Saarbrücken, Germany

    Contact: Study coordinator (Axel Matzdorff, Prof PhD)
    Contact: Principal Investigator (Axel Matzdorff, Prof PhD)
  • Community based hemato-oncology medical office, Schkeuditz, Germany

    Contact: Study coordinator (Thomas Edelmann, PhD)
    Contact: Principal Investigator (Thomas Edelmann, PhD)
  • Kreiskrankenhaus Schotten, Schotten, Germany

    Contact: Study coordinator (M Graubner, PhD)
    Contact: Principal Investigator (M Graubner, PhD)
  • Community based hemato-oncology medical office, Schweinfurt, Germany

    Contact: Study coordinator (Reginhard von Hirschhausen, PhD)
    Contact: Principal Investigator (Reginhard von Hirschhausen, PhD)
  • Community based hemato-oncology medical office, Siegen, Germany

    Contact: Study coordinator (F A Trux, PhD)
    Contact: Principal Investigator (F A Trux, PhD)
  • St.-Marien-Krankenhaus, Siegen, Germany

    Contact: Study coordinator (Winfried Gassmann, PhD)
    Contact: Principal Investigator (Winfried Gassmann, PhD)
  • Diakonie - Klinikum Stuttgart, Stuttgart, Germany

    Contact: Study coordinator (Else Heidemann, Prof PhD)
    Contact: Principal Investigator (Else Heidemann, Prof. PhD)
  • Community based hemato-oncology medical office, Trier, Germany

    Contact: Study coordinator (Hans P Laubenstein, PhD)
    Contact: Principal Investigator (Hans P Laubenstein, PhD)
  • Community based hemato-oncology medical office, Tübingen, Germany

    Contact: Study coordinator (Swen H Jacki, PhD)
    Contact: Principal Investigator (Swen H Jacki, PhD)
  • University Clinic Ulm, Ulm, Germany

    Contact: Study coordinator (Christian Buske, Prof PhD)
    Contact: Principal Investigator (Christian Buske, Prof PhD)
  • Städtisches Krankenhaus Villingen, Villingen-Schwenningen, Germany

    Contact: Study coordinator (Wolfram Brugger, Prof PhD)
    Contact: Principal Investigator (Wolfram Brugger, Prof. PhD)
  • Community based hemato-oncology medical office, Weilheim, Germany

    Contact: Study coordinator (Michael Sandherr, PhD)
    Contact: Principal Investigator (Michael Sandherr, PhD)
  • Sophien- und Hufeland Klinikum, Weimar, Germany

    Contact: Study coordinator (Thomas Hoffmann, Phd)
    Contact: Principal Investigator (Thomas Hoffmann, PhD)
  • Asklepios Nordseeklinik, Westerland, Germany

    Contact: Study coordinator (Willy Nettekoven, PhD)
    Contact: Principal Investigator (Willy Nettekoven, PhD)
  • Community based hemato-oncology medical office, Wiesbaden, Germany

    Contact: Study coordinator (Klaus M Josten, PhD)
    Contact: Principal Investigator (Klaus M Josten, PhD)
  • Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany

    Contact: Study coordinator (Norbert Frickhofen, Prof PhD)
    Contact: Principal Investigator (Norbert Frickhofen, Prof PhD)
  • Community based hemato-oncology medical office, Wilhelmshaven, Germany

    Contact: Study coordinator (Yolanda Rodemer, PhD)
    Contact: Principal Investigator (Yolanda Rodemer, PhD)
  • Community based hemato-oncology medical office, Wolfsburg, Germany

    Contact: Study coordinator (Joachim Haessner, PhD)
    Contact: Principal Investigator (Joachim Haessner, PhD)
Study leads
  • Mathias J Rummel, Prof. Dr.

    Principal Investigator

    Justus-Liebig-University | University Hospital | Medicinal Clinic IV